BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30778047)

  • 1. H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis.
    Zhang L; Yang Z; Huang W; Wu J
    Cell Death Dis; 2019 Feb; 10(3):168. PubMed ID: 30778047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.
    Zhang L; Yang Z; Trottier J; Barbier O; Wang L
    Hepatology; 2017 Feb; 65(2):604-615. PubMed ID: 27770549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.
    Liu C; Yang Z; Wu J; Zhang L; Lee S; Shin DJ; Tran M; Wang L
    Hepatology; 2018 May; 67(5):1768-1783. PubMed ID: 29140550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19.
    Tian X; Wang Y; Lu Y; Wang W; Du J; Chen S; Zhou H; Cai W; Xiao Y
    Cell Death Dis; 2021 Jun; 12(7):646. PubMed ID: 34168124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.
    Song Y; Liu C; Liu X; Trottier J; Beaudoin M; Zhang L; Pope C; Peng G; Barbier O; Zhong X; Li L; Wang L
    Hepatology; 2017 Oct; 66(4):1183-1196. PubMed ID: 28407375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
    Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia.
    Xiao Y; Liu R; Li X; Gurley EC; Hylemon PB; Lu Y; Zhou H; Cai W
    Hepatology; 2019 Nov; 70(5):1658-1673. PubMed ID: 31063660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA HOTTIP enhances the fibrosis of lung tissues by regulating the miR‑744‑5p/PTBP1 signaling axis.
    Li J; Chai W; Zhao Z; Zhou Y; Wu Q
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway.
    Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y
    FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑133b alleviates doxorubicin‑induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2.
    Li Z; Ye Z; Ma J; Gu Q; Teng J; Gong X
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 33982775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions.
    Li X; Liu R; Wang Y; Zhu W; Zhao D; Wang X; Yang H; Gurley EC; Chen W; Hylemon PB; Zhou H
    Cells; 2020 Jan; 9(1):. PubMed ID: 31940841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice.
    Li X; Liu R; Yang J; Sun L; Zhang L; Jiang Z; Puri P; Gurley EC; Lai G; Tang Y; Huang Z; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Sep; 66(3):869-884. PubMed ID: 28271527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-326 Inhibits Inflammation and Promotes Autophagy in Silica-Induced Pulmonary Fibrosis through Targeting TNFSF14 and PTBP1.
    Xu T; Yan W; Wu Q; Xu Q; Yuan J; Li Y; Li P; Pan H; Ni C
    Chem Res Toxicol; 2019 Nov; 32(11):2192-2203. PubMed ID: 31642316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
    Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
    J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
    Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
    J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization.
    Han X; Guo B; Zhao S; Li Y; Zhu J; He Y; Wang J; Yao Q; Shao S; Zheng L; Shi Z; Han T; Hong W; Zhang K
    Cell Mol Biol Lett; 2023 Oct; 28(1):77. PubMed ID: 37805473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
    Li M; Zhou Y; Zhu H; Xu LM; Ping J
    J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.